Dewilde S., Anderson R.The cost-effectiveness of screening programs using single and multiple birth cohort simulations: a comparison using a model of cervical cancer. Med Decis Making. 2004;24:486-92.
2.
Karnon J., Brennan A., Akehurst R.A critique and impact analysis of decision modeling assumptions. Med Decis Making. 2007; 27:491-9.
3.
Hoyle M., Anderson R.Whose cost and benefits? Why economic evaluations should simulate both prevalent and all future incident patient cohorts. Med Decis Making . 2010;30:426-37.
4.
Gaspoz JM, Coxson PG, Goldman PA, et al. Cost-effectiveness of aspirin, clopidogrel, or both for secondary prevention of coronary heart disease. N Engl J Med. 2002;346:1800-6.
5.
Habbema JD, Lubbe JT, van Oortmarssen GJ, van der Maas PJA simulation approach to cost-effectiveness and cost-benefit calculations of screening for the early detection of disease. Eur J Operation Res. 1987;29:159-66.
6.
Fenwick E., Claxton K., Sculpher M.The value of implementation and the value of information: combined and uneven development. Med Decis Making. 2008;28:21-32.
